Melhores Astrocitoma Astrocitoma em Israel - TOP-7 médicos

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Mais de 900 procedimentos realizados – O Dr. Blumental é um neuro-oncologista altamente experiente e diretor do Serviço de Neuro-oncologia do Sourasky Medical Center.

• 29 anos de experiência em oncologia
• Diretor do Serviço de Neuro-oncologia do Huntsman Cancer Institute
• Formado no Memorial Sloan-Kettering Cancer Center
• Especializado em tratamentos oncológicos com alta taxa de sucesso

O Dr. Felix Bokstein lidera a Clínica de Neuro-oncologia no Ichilov – um dos maiores e mais avançados hospitais de Israel, com foco específico em tumores cerebrais.

• O seu foco principal é o tratamento de tumores complexos do cérebro e da medula espinhal.
• Como chefe da clínica, supervisiona uma unidade dedicada à neuro-oncologia.
• A sua experiência inclui a gestão de gliomas, astrocitomas e outras neoplasias malignas do SNC.
• Integra quimioterapia, terapias direcionadas e opções de ensaios clínicos nos planos de tratamento.

O Professor Zvi Ram chefia a Associação Europeia de Sociedades Neurocirúrgicas (EANS) – um cargo de alto nível que destaca a sua liderança na área.

• Especializar-se em cirurgia minimamente invasiva e técnicas de mapeamento cerebral
• Ser especialista em operações neurocirúrgicas, incluindo estimulação cerebral profunda (DBS)
• Realizar neurocirurgia guiada por imagem para tumores cerebrais, formado na Grécia e na Suíça
• Liderar pesquisas em terapias de base genética para cancro cerebral
• Ser distinguido com o Prémio Borenstein da Brain & Behavior Research Foundation

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.